One of the less obvious after-effects of the Enron debacle, note industry dealmakers and CFOs, has been the increasing reluctance of accountants to give clear answers. "They're more scared than we are" about issuing opinions, notes one head of business development.
And that's not what company executives want to hear during what Peter Wirth, Genzyme Corp. 's EVP and chief...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?